Meyer Handelman Company’s Boston Scientific BSX Stock Holding History

Meyer Handelman Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,146	Closed	-$264K	–	214
2024 Q3	$264K	Hold	3,146	–	–	0.01%	195
2024 Q2	$242K	Buy	+3,146	New	+$230K	0.01%	194
2020 Q3	–	Sell	-24,400	Closed	-$856K	–	182
2020 Q2	$856K	Sell	24,400 -6,000	-20%	-$216K	0.05%	141
2020 Q1	$992K	Hold	30,400	–	–	0.06%	127
2019 Q4	$1.38M	Buy	30,400 +1,600	+6%	+$67K	0.07%	130
2019 Q3	$1.17M	Hold	28,800	–	–	0.06%	131
2019 Q2	$1.24M	Buy	28,800 +2,400	+9%	+$92.3K	0.06%	134
2019 Q1	$1.05M	Hold	26,400	–	–	0.05%	134
2018 Q4	$932K	Hold	26,400	–	–	0.05%	133
2018 Q3	$1.02M	Hold	26,400	–	–	0.05%	138
2018 Q2	$864K	Buy	+26,400	New	+$796K	0.04%	140

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meyer Handelman Company's BSX Position: Q4 2024 in Review

Meyer Handelman Company sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 3,146 shares — an estimated $264K sold.

Meyer Handelman Company first reported a position in BSX in Q2 2018 and held it in 11 quarters. The position peaked at $1.38M in Q4 2019. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

Meyer Handelman Company reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
Meyer Handelman Company sold 3,146 Boston Scientific shares in Q4 2024, an estimated $264K.
Meyer Handelman Company first reported a position in Boston Scientific in Q2 2018 and held it in 11 quarters.
Meyer Handelman Company's Boston Scientific position peaked at $1.38M in Q4 2019.
1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Meyer Handelman Company's 13F filing for Q4 2024, filed 14 Jan 2025.